Concepedia

Apurva Prakash

AP

Statistics

Publications

28

Citations

2.5K

H-Index

22

Active since

1975

Affiliations

Eli Lilly (United States)(Current)

University of Pennsylvania

University of Arkansas for Medical Sciences

Rady Children's Hospital-San Diego

Massachusetts General Hospital

Apurva Prakash is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacotherapy, and antidepressant pharmacotherapy.

Publications per year

1975–2025

28

Publications

28

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

Gina A. Montealegre Sanchez, Adam Reinhardt, Suzanne Ramsey et al. · Journal of Clinical Investigation · 2018 · 521 citations · Full text

, , +17

The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders

John T. Farrar, Yili Pritchett, Michael J. Robinson et al. · Journal of Pain · 2009 · 252 citations

, , +17

Fluoxetine Versus Placebo in Posttraumatic Stress Disorder

Ferenc Martényi, Eileen B. Brown, Harry Zhang et al. · The Journal of Clinical Psychiatry · 2002 · 216 citations

, , +13

Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder

Anita H. Clayton, Susan G. Kornstein, Apurva Prakash et al. · The Journal of Sexual Medicine · 2007 · 149 citations

, , +14

Fluoxetine <i>v</i>. placebo in prevention of relapse in post-traumatic stress disorder

Ferenc Martényi, Eileen B. Brown, Harry Zhang et al. · The British Journal of Psychiatry · 2002 · 132 citations · Full text

, , +16

1–5 of 28